Microba Life Sciences Ltd has released a press release.
H1 FY23 Interim Report
Filed with ASX ·
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- US Distribution Agreement Signed with Luminary Health
- Positive first animal data for Cancer Program
- Q2 FY23 Quarterly Activities Report & Appendix 4C
- SYNLAB Agreements Signed in Italy and Portugal
- Sonic Investment & Partnership Investor Presentation
Later from Microba Life Sciences
- Microba Launches Next Generation Healthcare Testing
- SYNLAB Agreements Signed in Turkiye and Czech Republic
- Microba Receives Ethics Approval for Phase 1 Clinical Trial
- SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia
- Q3 FY23 Quarterly Activities Report & Appendix 4C
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences